Pradžia › Epilepsija › Ilinoisas
Epilepsija klinikiniai tyrimai Ilinoisas
7 tyrimai dėl Epilepsija ieško dalyvių vietose Ilinoisas.
Miestai Ilinoisas
Oficialus tyrimo tekstas (anglų kalba)
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
- Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviai2 fazė
1 Day – 6 Months · Visoms lytims · Atnaujinta 2026-10-02 · NCT05104983Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Re:Cognition Health-Chicago, Chicago
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07594119A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Southern Illinois University School of Medicine, Springfield
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-10 · NCT05667142Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Renkami dalyviaiStebimasis tyrimas
Iki 26 metų · Visoms lytims · Atnaujinta 2026-08-06 · NCT05374824A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Praxis Research Site, Chicago
Renkami dalyviai3 fazė
1 Day – 18 Years · Visoms lytims · Atnaujinta 2026-08-03 · NCT07019922Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Rush University Medical Center, Chicago
- University of Chicago, Chicago
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-06-09 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Southern Illinois University School of Medicine, Springfield
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-14 · NCT05716100Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.